Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN1 | Q05586 | 2/20 | 0.42 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.42 |
| ▸ | BRD4 | O60885 | 1/20 | 0.41 |
| ▸ | BRD2 | P25440 | 1/20 | 0.41 |
| ▸ | PER2 | O15055 | 1/20 | 0.33 |
| ▸ | CRY2 | Q49AN0 | 1/20 | 0.33 |
| ▸ | EHMT2 | Q96KQ7 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | INMT | O95050 | 2/20 | 0.31 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16498173 | 0.85 | — | — | |
| SCHEMBL761689 | 0.85 | — | — | |
| Hydrochloric Acid SCHEMBL29127408 | 0.83 | GRIN1 (0.37) | GRIN1GRIN2ABRD4BRD2EHMT2 | |
| SCHEMBL23168692 | 0.77 | GRIN1 (0.40) | GRIN1GRIN2ABRD4BRD2EHMT2 | |
| SCHEMBL9197159 | 0.77 | GRIN1 (0.40) | GRIN1GRIN2ABRD4BRD2EHMT2 | |
| SCHEMBL19174271 | 0.77 | GRIN1 (0.40) | GRIN1GRIN2ABRD4BRD2EHMT2 | |
| SCHEMBL16190002 | 0.76 | GRIN1 (0.42) | GRIN1GRIN2ABRD4BRD2EHMT2 | |
| SCHEMBL9697645 | 0.74 | PER2 (0.35) | PER2CRY2RAB9ASMN1; SMN2POLB | |
| SCHEMBL14378051 | 0.74 | POLB (0.41) | PER2CRY2EHMT2RAB9ASMN1; SMN2 | |
| SCHEMBL27046535 | 0.74 | GRIN1 (0.41) | GRIN1GRIN2ABRD4BRD2EHMT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103102519-B | Rubber composition for tire tread and use its pneumatic tire | 横滨橡胶株式会社 | 2018-06-01 | — | — | CN | disclosed |
| WO-2017049068-A1 | HETEROARYL COMPOUNDS AS IRAK INHIBITORS AND USES THEREOF | MERCK PATENT GMBH (DE) | 2017-03-23 | — | — | WO | disclosed |
| US-20170081317-A1 | HETEROARYL COMPOUNDS AS IRAK INHIBITORS AND USES THEREOF | MERCK PATENT GMBH (DE) | 2017-03-23 | — | — | US | disclosed |
| CN-104220510-B | Rubber composition for tire tread | THE YOKOHAMA RUBBER CO.,LTD. (JP) | 2016-04-13 | — | — | CN | disclosed |
| CN-104302696-B | Rubber composition for tire | THE YOKOHAMA RUBBER CO.,LTD. (JP) | 2016-01-20 | — | — | CN | disclosed |
| US-9212171-B2 | Ethynyl compounds | HOFFMANN-LA ROCHE INC. (US) | 2015-12-15 | — | — | US | disclosed |
| US-20150119384-A1 | ETHYNYL COMPOUNDS | F. HOFFMANN-LA ROCHE AG (CH) | 2015-04-30 | — | — | US | disclosed |
| EP-2702051-B1 | ETHYNYL DERIVATIVES AS POSITIVE ALLOSTERIC MODULATORS OF THE MGLUR5 | HOFFMANN LA ROCHE (CH) | 2015-03-04 | — | — | EP | disclosed |
| US-8957213-B2 | Ethynyl compounds | HOFFMAN-LA ROCHE INC. (US) | 2015-02-17 | — | — | US | disclosed |
| CN-104302696-A | Rubber composition for tire | YOKOHAMA RUBBER CO LTD | 2015-01-21 | — | — | CN | disclosed |
| US-20100087442-A1 | DIKETOHYDRAZINE DERIVATIVE COMPOUNDS AND DRUGS CONTAINING THE COMPOUNDS AS THE ACTIVE INGREDIENT | ONO PHARMACEUTICAL CO., LTD (JP) | 2010-04-08 | — | — | US | disclosed |
| US-20100087442-A1 | DIKETOHYDRAZINE DERIVATIVE COMPOUNDS AND DRUGS CONTAINING THE COMPOUNDS AS THE ACTIVE INGREDIENT | ONO PHARMACEUTICAL CO., LTD (JP) | 2010-04-08 | — | — | US | disclosed |
| US-7655804-B2 | N-[(1S)-3-{(2Z)-2-[(4R)-3,4-dimethyl-1,3-thiazolidin-2-ylidene]hydrazino}-2,3-dioxo-1-(tetrahydro-2H-pyran-4-yl)propyl]cycloheptanecarboxamide; cysteine protease inhibitors; for the treatment of inflammatory, immune, ischemic, respiratory,circulatory, neuronal, blood, hepatic and metabolic diseases | ONO PHARMACEUTICAL CO., LTD. (JP) | 2010-02-02 | — | — | US | disclosed |
| US-7655804-B2 | N-[(1S)-3-{(2Z)-2-[(4R)-3,4-dimethyl-1,3-thiazolidin-2-ylidene]hydrazino}-2,3-dioxo-1-(tetrahydro-2H-pyran-4-yl)propyl]cycloheptanecarboxamide; cysteine protease inhibitors; for the treatment of inflammatory, immune, ischemic, respiratory,circulatory, neuronal, blood, hepatic and metabolic diseases | ONO PHARMACEUTICAL CO., LTD. (JP) | 2010-02-02 | — | — | US | disclosed |
| CN-101155868-A | Modified butadiene-based polymer composition | ASAHI CHEMICAL CORP (JP) | 2008-04-02 | — | — | CN | disclosed |
| CN-1649907-A | Modified polymer and composition containing same | ASAHI CHEMICAL IND (JP) | 2005-08-03 | — | — | CN | disclosed |
| US-5239003-A | PROCESS FOR PREPARATION OF STYRENE RESIN COMPOSITION AND STYRENE RESIN COMPOSITION | NIPPON ZEON CO., LTD. (JP) | 1993-08-24 | — | — | US | disclosed |
| US-5155161-A | Living polymer modified by lactam, urea, amino ketone or aldehyde or thio analogs, followed by hydrolysis | NIPPON ZEON CO., LTD. (JP) | 1992-10-13 | — | — | US | disclosed |
| EP-0488346-A1 | Process for preparation of styrene resin composition and styrene resin composition | NIPPON ZEON CO., LTD. (JP) | 1992-06-03 | — | — | EP | disclosed |
| US-5001113-A | Di- or tripeptide renin inhibitors containing lactam conformational restriction in ACHPA | MERCK & CO., INC. (US) | 1991-03-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170081317-A1 | HETEROARYL COMPOUNDS AS IRAK INHIBITORS AND USES THEREOF | IRAK2, IRAK3, IRAK1 | GRIN1 990/4885GRIN2A 1933/4885BRD4 176/4885 |
| US-20100087442-A1 | DIKETOHYDRAZINE DERIVATIVE COMPOUNDS AND DRUGS CONTAINING THE COMPOUNDS AS THE ACTIVE INGREDIENT | SERPINB1, CTSZ, ELANE | GRIN1 505/4885GRIN2A 1408/4885BRD4 614/4885 |
| US-20150119384-A1 | ETHYNYL COMPOUNDS | GRM5, GRM1, GRM2 | GRIN1 7/4885GRIN2A 13/4885BRD4 840/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.